Johnson & Johnson’s single-dose vaccine is effective against COVID-19, FDA says
Johnson & Johnson’s single-dose vaccine protects against, according to an analysis by U.S. regulators Wednesday. The analysis sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.
The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.
However, Johnson & Johnson expects to COVID-19 vaccine by the end of February, with under 4 million to be ready to ship. The disclosure of the shortfall by Johnson & Johnson is the first public measure of…of its commitment to deliver 10 million doses of its